AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33523933 — intervention group
Group type: EXPERIMENTAL
Intervention: Political leaders in nondemocracies
Number of subjects: 0
Study 33523933 — intervention group
Group type: COMPARATOR
Intervention: Chief executive officers
Number of subjects: 0
Study 33523933 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports coaches
Number of subjects: 0
Study 33327282 — intervention group
Group type: EXPERIMENTAL
Intervention: Family nursing with the assistance of network (FNAN)
Number of subjects: 112
Study 33327282 — intervention group
Group type: COMPARATOR
Intervention: Routine family nursing care (Control Group)
Number of subjects: 112
Study 35412099 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation (RCA)
Number of subjects: 41
Study 35412099 — intervention group
Group type: COMPARATOR
Intervention: Heparin-free protocol
Number of subjects: 41
Study 34016302 — intervention group
Group type: EXPERIMENTAL
Intervention: VR PRE after 15-second VR smoking memory retrieval (G1)
Number of subjects: 46
Study 34016302 — intervention group
Group type: COMPARATOR
Intervention: Standard extinction procedure after retrieval (G3)
Number of subjects: 46
Study 34016302 — intervention group
Group type: COMPARATOR
Intervention: No exposure to smoking memory retrieval (G2)
Number of subjects: 46
Study 32507535 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 6 drops of 40% damask rose essential oil
Number of subjects: 120
Study 32507535 — intervention group
Group type: COMPARATOR
Intervention: Placebo (6 drops of distilled water)
Number of subjects: 120
Study 32507535 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study 34410498 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide (White Class 10%, FGM) applied once daily for 60 min to the buccal surface for 14 days
Number of subjects: 25
Study 34410498 — intervention group
Group type: COMPARATOR
Intervention: 10% hydrogen peroxide (White Class 10%, FGM) applied once daily for 60 min to the lingual surface for 14 days
Number of subjects: 25
Study 34551492 — intervention group
Group type: EXPERIMENTAL
Intervention: PSI-TKA (n=40)
Number of subjects: 80
Study 34551492 — intervention group
Group type: COMPARATOR
Intervention: CI-TKA (n=40)
Number of subjects: 80
Study 32757302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 75
Study 32757302 — intervention group
Group type: COMPARATOR
Intervention: Pembrolizumab plus acalabrutinib
Number of subjects: 75
Study 32757302 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 75
Study 32757302 — intervention group
Group type: COMPARATOR
Intervention: Acalabrutinib plus pembrolizumab
Number of subjects: 75
Study 32757302 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment
Number of subjects: 75
Study 36102400 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed method (specially developed for this study)
Number of subjects: 139
Study 36102400 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-Led Weaning (PLW)
Number of subjects: 139
Study 36102400 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby-Led Introduction to SolidS (BLISS)
Number of subjects: 139
Study 36102400 — intervention group
Group type: COMPARATOR
Intervention: PLW and BLISS methods (non-adherence)
Number of subjects: 139
Study 33084088 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor blockade (using exendin9-39) before surgery
Number of subjects: 9
Study 33084088 — intervention group
Group type: EXPERIMENTAL
Intervention: RYGB
Number of subjects: 9
Study 33084088 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor blockade after RYGB
Number of subjects: 9
Study 33084088 — intervention group
Group type: EXPERIMENTAL
Intervention: Default mode and right frontoparietal network connectivity changes after RYGB
Number of subjects: 9
Study 32091596 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dose bivalent HPV vaccine
Number of subjects: 0
Study 32091596 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-dose bivalent HPV vaccine
Number of subjects: 0
Study 32091596 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated women
Number of subjects: 0
Study 35182925 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine-based chemotherapy
Number of subjects: 419
Study 35182925 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 419
Study 34078367 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 86
Study 34078367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 32192811 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01 co-administered with YF and MR vaccines
Number of subjects: 709
Study 32192811 — intervention group
Group type: COMPARATOR
Intervention: RTS,S/AS01 alone
Number of subjects: 709
Study 32192811 — intervention group
Group type: COMPARATOR
Intervention: YF and MR vaccines alone
Number of subjects: 709
Study 36431088 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted personalized diet based on microbiome analysis
Number of subjects: 50
Study 36431088 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (sodium picosulfate plus laxatives, enemas, increased fiber, and fluid intake)
Number of subjects: 50
Study 33046141 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceride formulation of EPA + DHA (2.8 g)
Number of subjects: 20
Study 33046141 — intervention group
Group type: COMPARATOR
Intervention: Ethyl ester formulation of EPA + DHA (2.8 g)
Number of subjects: 20
Study 34595695 — intervention group
Group type: EXPERIMENTAL
Intervention: Entertainment-education video
Number of subjects: 111
Study 34595695 — intervention group
Group type: COMPARATOR
Intervention: Informational brochure (flyer)
Number of subjects: 111
Study 32083443 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session cardiac rehabilitation
Number of subjects: 112
Study 32083443 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-session cardiac rehabilitation
Number of subjects: 112
Study 36454119 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 24477
Study 36454119 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting CSS
Number of subjects: 24477
Study 33359437 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal mucosal resurfacing (DMR) combined with glucagon-like peptide-1 receptor agonist (GLP-1RA) (liraglutide) and lifestyle counseling
Number of subjects: 16
Study 36192223 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application (app) for oral hygiene guidance and motivation
Number of subjects: 8
Study 36192223 — intervention group
Group type: COMPARATOR
Intervention: Standard oral hygiene (SOH) instructions
Number of subjects: 8
Study 33909330 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (SPL) 200 mg/day
Number of subjects: 56
Study 33909330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 32500725 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate switch from amiodarone to dronedarone
Number of subjects: 284
Study 32500725 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week washout before switching to dronedarone
Number of subjects: 284
Study 32500725 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone pharmacokinetics
Number of subjects: 284
Study 32500725 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone (control group)
Number of subjects: 284
Study 34399650 — intervention group
Group type: EXPERIMENTAL
Intervention: Remodeled bicycle pedal training for 6 weeks
Number of subjects: 26
Study 34399650 — intervention group
Group type: COMPARATOR
Intervention: Nontraining group (FAI-NT)
Number of subjects: 26
Study 33445588 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatosensory rehabilitation in addition to standard physical therapy for 8 weeks
Number of subjects: 30
Study 33445588 — intervention group
Group type: COMPARATOR
Intervention: Standard physical therapy for 8 weeks
Number of subjects: 30
Study 35787730 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandate (N = 229)
Number of subjects: 929
Study 35787730 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative monetary incentive (N = 244)
Number of subjects: 929
Study 35787730 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive monetary incentive (N = 228)
Number of subjects: 929
Study 35787730 — intervention group
Group type: COMPARATOR
Intervention: Information provision (N = 228)
Number of subjects: 929
Study 32193981 — intervention group
Group type: EXPERIMENTAL
Intervention: LIVE‐LiFE intervention (strength and balance training integrated into daily habits, 8 visits over 12 weeks, plus US$500 in home safety changes, vision contrast screening, and medication recommendations)
Number of subjects: 37
Study 32193981 — intervention group
Group type: EXPERIMENTAL
Intervention: LIVE‐LiFE intervention
Number of subjects: 37
Study 32193981 — intervention group
Group type: COMPARATOR
Intervention: Control condition (fall prevention materials and individualized fall risk summary)
Number of subjects: 37
Study 34673998 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperosmolar dextrose injection (12.5%)
Number of subjects: 70
Study 34673998 — intervention group
Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 70
Study 32746140 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-supervised feature learning method utilizing multi-modal data (including FFA modality)
Number of subjects: 0
Study 35759333 — intervention group
Group type: EXPERIMENTAL
Intervention: myDEx intervention (6-session content over 3 months)
Number of subjects: 180
Study 35759333 — intervention group
Group type: EXPERIMENTAL
Intervention: myDEx intervention
Number of subjects: 180
Study 35759333 — intervention group
Group type: COMPARATOR
Intervention: Attention-control arm
Number of subjects: 180
Study 34257675 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3FA concentrate 2000 mg (Group A)
Number of subjects: 58
Study 34257675 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3FA concentrate 2000 mg + PCC200 mcg (Group B)
Number of subjects: 58
Study 34257675 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3FA concentrate 2000 mg + PCC400 mcg (Group C)
Number of subjects: 58
Study 35193041 — intervention group
Group type: EXPERIMENTAL
Intervention: Deficit on visual capacity
Number of subjects: 693
Study 35193041 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent impairment of locomotor capacity
Number of subjects: 693
Study 35193041 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent impairment of psychological capacity
Number of subjects: 693
Study 33824980 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training at home on a tablet device (N=24)
Number of subjects: 47
Study 33824980 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (N=21, completed ≥10 training sessions)
Number of subjects: 47
Study 33824980 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (N=23)
Number of subjects: 47
Study 35164864 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication treatment for one week
Number of subjects: 5355
Study 35164864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5355
Study 34623318 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS program (n=50)
Number of subjects: 100
Study 34623318 — intervention group
Group type: COMPARATOR
Intervention: Weekly text assessment (n=50)
Number of subjects: 100
Study 33238431 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacto-Ovo-Vegetarian Diet (VD)
Number of subjects: 31
Study 33238431 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric Meat Diet (MD)
Number of subjects: 31
Study 33098496 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural radionuclide concentrations (226Ra, 232Th, 40K)
Number of subjects: 26
Study 33098496 — intervention group
Group type: EXPERIMENTAL
Intervention: Radium equivalent activity (Raeq), hazard indices (Hex, Hin), radioactivity level indices (Iϒr, Iα, AUI)
Number of subjects: 26
Study 33098496 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor and outdoor dose rates (Ḋ), age‐dependent annual effective doses (AED), organ‐specific doses, lifetime attributable cancer risk
Number of subjects: 26
Study 33098496 — intervention group
Group type: EXPERIMENTAL
Intervention: Radon/thoron exhalation rate
Number of subjects: 26
Study 33572955 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness-raising interventions tailored to reduce stigmatising beliefs and attitudes among primary care professionals (PC)
Number of subjects: 0
Study 33572955 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness-raising interventions tailored to reduce stigmatising beliefs and attitudes among mental health professionals (MH)
Number of subjects: 0
Study 33572955 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33094958 — intervention group
Group type: COMPARATOR
Intervention: Empirical therapy (triple therapy with esomeprazole, amoxicillin, and clarithromycin for 10 days)
Number of subjects: 72
Study 33094958 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored therapy (triple or quadruple therapy with esomeprazole, metronidazole, tetracycline, and bismuth for 10 days based on genotype markers of resistance)
Number of subjects: 72
Study 33094958 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored therapy
Number of subjects: 72
Study 33094958 — intervention group
Group type: COMPARATOR
Intervention: Empirical therapy
Number of subjects: 72
Study 34762351 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra 100 mg daily intravenously
Number of subjects: 30
Study 34762351 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard COVID-19 pharmacotherapy)
Number of subjects: 30
Study 34032829 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of 20% hypertonic saline solution plus standard care
Number of subjects: 370
Study 34032829 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (control)
Number of subjects: 370
Study 32398077 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum family planning intervention including counseling on PPFP and PPIUD insertion during delivery services
Number of subjects: 15264
Study 32398077 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum family planning intervention with universal counseling
Number of subjects: 15264
Study 35762095 — intervention group
Group type: EXPERIMENTAL
Intervention: OHI (electric toothbrush and intensive oral hygiene manoeuvre adaptation)
Number of subjects: 140
Study 35762095 — intervention group
Group type: COMPARATOR
Intervention: no-OHI (routine habits)
Number of subjects: 140
Study 34199448 — intervention group
Group type: EXPERIMENTAL
Intervention: MaP-BC intervention (n = 18)
Number of subjects: 35
Study 34199448 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care only, n = 17)
Number of subjects: 35
Study 32207659 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy defibrillators (CRT-D)
Number of subjects: 12638
Study 32207659 — intervention group
Group type: COMPARATOR
Intervention: Optimal pharmacologic therapy (OPT)
Number of subjects: 12638
Study 32207659 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillators (ICD)
Number of subjects: 12638
Study 32207659 — intervention group
Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy pacemakers (CRT-P)
Number of subjects: 12638
Study 35573335 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training (BPT)
Number of subjects: 30
Study 35573335 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 30
Study 33097422 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous antibiotic prophylaxis (CAP)
Number of subjects: 105
Study 33097422 — intervention group
Group type: COMPARATOR
Intervention: Control group without CAP
Number of subjects: 105
Study 36456409 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication reconciliation (MC)
Number of subjects: 0
Study 36456409 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32928024 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 149
Study 32928024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 32928024 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine withdrawal (24 h)
Number of subjects: 149
Study 32928024 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum smoking
Number of subjects: 149
Study 34208162 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 524
Study 33143640 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin (30 ml/day)
Number of subjects: 50
Study 33143640 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 50
Study 33811460 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on radiologic findings
Number of subjects: 3708
Study 33811460 — intervention group
Group type: COMPARATOR
Intervention: American nomogram
Number of subjects: 3708
Study 33811460 — intervention group
Group type: COMPARATOR
Intervention: Korean/Japanese nomogram
Number of subjects: 3708
Study 33372320 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week aerobic exercise intervention
Number of subjects: 31
Study 34593990 — intervention group
Group type: EXPERIMENTAL
Intervention: AdVEGF-D gene therapy (GT)
Number of subjects: 30
Study 34593990 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 33818845 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for insomnia (CBT‐I)
Number of subjects: 46
Study 33818845 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 46
Study 36163030 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored cognitive-behavioural intervention (5 sessions, 30-35 min each, weekly)
Number of subjects: 80
Study 36163030 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study 34297333 — intervention group
Group type: EXPERIMENTAL
Intervention: FRAMES Group
Number of subjects: 70
Study 34297333 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 70
Study 34297333 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Groups
Number of subjects: 70
Study 32326354 — intervention group
Group type: COMPARATOR
Intervention: Control (CON; 19 °C, 8h sleep opportunity)
Number of subjects: 66
Study 32326354 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot (HOT; 33 °C, 8h sleep opportunity)
Number of subjects: 66
Study 32326354 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot and Sleep Restricted (HOT + SR; 33 °C, 4‐h sleep opportunity)
Number of subjects: 66
Study 32326354 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Restricted (SR; 19 °C, 4‐h sleep opportunity)
Number of subjects: 66
Study 35465859 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based monitoring systems (VMSs) for auditing hand hygiene compliance
Number of subjects: 111
Study 32357364 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMPT intervention (45 min, two times a week for 10 weeks)
Number of subjects: 49
Study 32357364 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMPT intervention
Number of subjects: 49
Study 32357364 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlisted, home training instructions)
Number of subjects: 49
Study 33812334 — intervention group
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel/Gemcitabine (NAB-P/G)
Number of subjects: 124
Study 33812334 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine (G)
Number of subjects: 124
Study 33093816 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter closure under transthoracic echocardiography (TTE) guidance
Number of subjects: 100
Study 33093816 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy guidance
Number of subjects: 100
Study 33514817 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilayer multimodal detection and prediction model using random forest (RF) classifier
Number of subjects: 1048
Study 35787730 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandate (N=229)
Number of subjects: 929
Study 35787730 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative monetary incentive (N=244)
Number of subjects: 929
Study 35787730 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive monetary incentive (N=228)
Number of subjects: 929
Study 35787730 — intervention group
Group type: COMPARATOR
Intervention: Information provision (N=228)
Number of subjects: 929
Study 34196693 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab arm (PA)
Number of subjects: 185
Study 34196693 — intervention group
Group type: COMPARATOR
Intervention: Control arm (CA)
Number of subjects: 185
Study 35743466 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual supervised exercise program throughout pregnancy, 3 days per week
Number of subjects: 157
Study 32843098 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose dexamethasone (16 mg/24 hours for 5 days followed by 8 mg/24 hours for 5 days) + standard ICU care
Number of subjects: 284
Study 32843098 — intervention group
Group type: COMPARATOR
Intervention: Standard ICU care
Number of subjects: 284
Study 32843098 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose dexamethasone + standard ICU care
Number of subjects: 284
Study 35550062 — intervention group
Group type: EXPERIMENTAL
Intervention: EXALT Model B Regular
Number of subjects: 15
Study 35550062 — intervention group
Group type: COMPARATOR
Intervention: aScope 4 Large
Number of subjects: 15
Study 35550062 — intervention group
Group type: EXPERIMENTAL
Intervention: EXALT Model B
Number of subjects: 15
Study 32198423 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergame intervention (24 weeks, 120 min/week, 2 sessions of 60 min each)
Number of subjects: 50
Study 32198423 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 50
Study 35908203 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound measured thickness of the fascia
Number of subjects: 90
Study 35908203 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound measured thickness of the fat pad
Number of subjects: 90
Study 35908203 — intervention group
Group type: EXPERIMENTAL
Intervention: Microvascular volume (MV) by contrast-enhanced ultrasound
Number of subjects: 90